These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 893592)

  • 41. Identification of novel hydrazine metabolites by 15N-NMR.
    Preece NE; Nicholson JK; Timbrell JA
    Biochem Pharmacol; 1991 May; 41(9):1319-24. PubMed ID: 2018564
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Binding of toxic metabolites of isoniazid by aconiazide.
    Held HR; Landi S
    J Pharm Sci; 1980 Nov; 69(11):1284-7. PubMed ID: 7452457
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of rifampicin and phenobarbital on the fate of isoniazid and hydrazine in vivo in rats.
    Noda A; Sendo T; Ohno K; Goto S; Noda H; Hsu KY
    Toxicol Lett; 1985 Jun; 25(3):313-7. PubMed ID: 4012807
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Determination of hydrazine in pharmaceuticals III: hydralazine and isoniazid using GLC.
    Matsui F; Robertson DL; Lovering EG
    J Pharm Sci; 1983 Aug; 72(8):948-51. PubMed ID: 6620156
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Classification of subjects as slow or rapid inactivators of isoniazid oral administration of a slow-release preparation of isoniazid and determination of the ratio of acetylisoniazid to isoniazid in urine.
    Kailasam S; Immanuel C; Nair NG; Radhakrishma S; Tripathy SP
    Indian J Med Res; 1975 Feb; 63(2):323-8. PubMed ID: 1213728
    [No Abstract]   [Full Text] [Related]  

  • 46. Urinary metabolic profile of isoniazid in patients who develop isoniazid-related liver damage.
    Timbrell JA; Wright JM
    Hum Toxicol; 1984 Dec; 3(6):485-95. PubMed ID: 6526396
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A specific rapid gaschromatographic assay for the determination of isoniazid N-acetylation: observation in rats with induced constant urine flow.
    Frater-Schröder M; Zbinden G
    Biochem Med; 1975 Nov; 14(3):274-84. PubMed ID: 1225329
    [No Abstract]   [Full Text] [Related]  

  • 48. Rifampin-induced release of hydrazine from isoniazid. A possible cause of hepatitis during treatment of tuberculosis with regimens containing isoniazid and rifampin.
    Sarma GR; Immanuel C; Kailasam S; Narayana AS; Venkatesan P
    Am Rev Respir Dis; 1986 Jun; 133(6):1072-5. PubMed ID: 3717759
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Plasma hydrazine concentrations in man after isoniazid and hydralazine administration.
    Blair IA; Mansilla Tinoco R; Brodie MJ; Clare RA; Dollery CT; Timbrell JA; Beever IA
    Hum Toxicol; 1985 Mar; 4(2):195-202. PubMed ID: 4007883
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Isoniazid-related hepatotoxicity: a study of the effect of rifampicin administration on the metabolism of acetylisoniazid in man.
    Jenner PJ; Ellard GA
    Tubercle; 1989 Jun; 70(2):93-101. PubMed ID: 2617692
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ethyl chloroformate as a derivatizing reagent for the gas chromatographic determination of isoniazid and hydrazine in pharmaceutical preparations.
    Khuhawar MY; Zardari LA
    Anal Sci; 2008; 24(11):1493-6. PubMed ID: 18997381
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analysis of isoniazid, acetylhydrazine and [15N2]acetylhydrazine in serum by capillary gas chromatography-ammonia chemical ionization mass spectrometry.
    Karlaganis G; Peretti E; Lauterburg BH
    J Chromatogr; 1987 Sep; 420(1):171-7. PubMed ID: 3667818
    [No Abstract]   [Full Text] [Related]  

  • 53. Classification of subjects as slow or rapid inactivators of isoniazid based on the ratio of acetylisoniazid to isoniazid in urine determined by a simple colorimetric method.
    Raghupati Sarma G; Kailasam S; Kannapiran M; Krishnaswami KV; Thomas L; Nair NG; Narayana AS
    Indian J Med Res; 1976 Oct; 64(10):1456-61. PubMed ID: 1017858
    [No Abstract]   [Full Text] [Related]  

  • 54. Isoniazid liver injury: clinical spectrum, pathology, and probable pathogenesis.
    Mitchell JR; Zimmerman HJ; Ishak KG; Thorgeirsson UP; Timbrell JA; Snodgrass WR; Nelson SD
    Ann Intern Med; 1976 Feb; 84(2):181-92. PubMed ID: 766682
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Metabolism of isoniazid and free hydrazine formation in isolated rat hepatocytes.
    Hirata M; Aso Y; Hsu KY; Tabata T; Matsuyama K; Noda A; Iguchi S
    J Pharmacobiodyn; 1981 Feb; 4(2):145-7. PubMed ID: 7277201
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Isoniazid acetylation in Gilbert's syndrome].
    Pereira-Filho RA; Sevá-Pereira A; de Magalhães AF
    Arq Gastroenterol; 1985; 22(4):172-5. PubMed ID: 3837656
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetic evaluation of aconiazide, a potentially less toxic isoniazid prodrug.
    Peloquin CA; James GT; Craig LD; Kim M; McCarthy EA; Iklé D; Iseman MD
    Pharmacotherapy; 1994; 14(4):415-23. PubMed ID: 7937278
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Simplification of isoniazid phenotyping procedure to promote its application in the chemotherapy of tuberculosis.
    Eidus L; Varughese P; Hodgkin MM; Hsu AH; McRae KB
    Bull World Health Organ; 1973; 49(5):507-16. PubMed ID: 4547302
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased incidence of isoniazid hepatitis in rapid acetylators: possible relation to hydranize metabolites.
    Mitchell JR; Thorgeirsson UP; Black M; Timbrell JA; Snodgrass WR; Potter WZ; Jollow HR; Keiser HR
    Clin Pharmacol Ther; 1975 Jul; 18(1):70-9. PubMed ID: 1149365
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Testing for heterogeneity in genetic polymorphism of N-acetylation using isoniazid by metameters--probit, logit, and arcsine transformation].
    Kohno H; Mori M; Katayama T
    Kekkaku; 1993 Aug; 68(8):511-6. PubMed ID: 8377325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.